[Tumor suppressor p53 gene: a potential target for cancer therapy?]

MDM2-TP53 Crossregulation: An Underestimated Target to Promote Loss of TP53 Function and Cell Survival.

Trends in cancer·2018

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.

Leukemia·2018

TP53: an oncogene in disguise.

Cell death and differentiation·2015

TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations.

Leukemia·2010

p53 alterations in human cancer: more questions than answers.

Oncogene·2007

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

Annals of oncology : official journal of the European Society for Medical Oncology·2006

[Gynecological cancer surgery: Is robotic surgery an advantage over conventional laparoscopy?]

Bulletin du cancer·2026

[Management of chronic pulmonary GVH in 2025, indication for lung transplantation (SFGM-TC)].

Bulletin du cancer·2026

[Guidelines for the essential data entry in the European Bone Marrow Transplant Registry].

Bulletin du cancer·2026

[Sexual and reproductive life of men and women with chronic myeloid leukemia: Opinion and practical considerations of the Fi-LMC group].

Bulletin du cancer·2026

[Transoral robotic surgery in head and neck cancers].

Bulletin du cancer·2026

[Who refer patients with multiple myeloma to hematology-oncology: A retrospective study at Hôtel-Dieu de France].

Bulletin du cancer·2026

Systematic analysis of network-driven adaptive resistance to CDK4/6 and oestrogen receptor inhibition using meta-dynamic network modelling.

eLife·2026

A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Comparative Effectiveness of Combination Therapy in Patients with Chronic Kidney Disease and Diabetes mellitus Type 2 using Real World Data.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

Efficacy and safety of durvalumab with or without tremelimumab in the treatment of metastatic non-small cell lung cancer: a meta-analysis of randomized controlled trials.

Proceedings (Baylor University. Medical Center)·2026

The non-canonical CDK2 activator SPY1 uses separable mechanisms to activate phosphorylated and unphosphorylated CDK2.

The Biochemical journal·2026

Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer.

Cancer research·2026

Related Experiment Videos

[Tumor suppressor p53 gene: a potential target for cancer therapy?]

Related Concept Videos

MDM2-TP53 Crossregulation: An Underestimated Target to Promote Loss of TP53 Function and Cell Survival.

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.

TP53: an oncogene in disguise.

TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations.

p53 alterations in human cancer: more questions than answers.

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

[Gynecological cancer surgery: Is robotic surgery an advantage over conventional laparoscopy?]

[Management of chronic pulmonary GVH in 2025, indication for lung transplantation (SFGM-TC)].

[Guidelines for the essential data entry in the European Bone Marrow Transplant Registry].

[Sexual and reproductive life of men and women with chronic myeloid leukemia: Opinion and practical considerations of the Fi-LMC group].

[Transoral robotic surgery in head and neck cancers].

[Who refer patients with multiple myeloma to hematology-oncology: A retrospective study at Hôtel-Dieu de France].

Systematic analysis of network-driven adaptive resistance to CDK4/6 and oestrogen receptor inhibition using meta-dynamic network modelling.

A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.

Comparative Effectiveness of Combination Therapy in Patients with Chronic Kidney Disease and Diabetes mellitus Type 2 using Real World Data.

Efficacy and safety of durvalumab with or without tremelimumab in the treatment of metastatic non-small cell lung cancer: a meta-analysis of randomized controlled trials.

The non-canonical CDK2 activator SPY1 uses separable mechanisms to activate phosphorylated and unphosphorylated CDK2.

Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer.

Related Experiment Videos

[Tumor suppressor p53 gene: a potential target for cancer therapy?]

Related Concept Videos

Related Articles